Interní Med. 2008; 10(9): 402-406

ACUTE MYOCARDIAL INFARCTION AND DIABETES MELLITUS

MUDr. Radka Adámková Ph.D
Interní kardiologická klinika FN a LF MU v Brně

Acute myocardial infarction as acute form of ischaemic heart disease represents a serious medical problem. Nearly one-third of all patients with acute myocardial infarction are patients with diabetes mellitus, where as nearly 70 % of patients with acute myocardial infarction already have impaired glucose metabolism (impaired glucose tolerance or diabetes mellitus). With the improvement of acute myocardial infarction therapy the total mortality decreases, but in patients with diabetes mellitus the mortality increases. Also the prevalence of diabetes mellitus increases in the population due to changes of life style. The prognosis of patients with acute myocardial infarction and diabetes mellitus comparing to nondiabetic patients is definitely worse. It is widely known that diabetic patients have different atherosclerotic affection of coronary arteries and because of this they need a specific therapy after acute myocardial infarction. Because of this both of the diseases are in front of interest of the doctors.

Keywords: Key words: acute myocardial infarction, diabetes mellitus, prognosis.

Published: November 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Adámková R. ACUTE MYOCARDIAL INFARCTION AND DIABETES MELLITUS. Interní Med. 2008;10(9):402-406.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adámková R, Janoušek S, Tomášek A, Tůmová J, Čermáková Z, Kaňovský J, Špinar J. Vstupní hladiny sérové glykemie jako rizikový faktor u pacientů s akutním infarktem myokardu. KARDIOL REV 2007; 9: 99-103.
    2. Asbun J, Villarreal FJ. The Pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy, J Am Coll Cardiol 2006; 47: 693-700. Go to original source... Go to PubMed...
    3. Berková M, Opavský J, Salinger J, Berka Z, Škrabka V. Stárne diabetické srdce rychleji? Interní Med. 2003; 5: 253-258.
    4. Čech J, Rosolová H, Mayer O, Šimon J, Plášková M, Cífková R. Rozdíly v intervenci rizikových faktorů ischemické choroby srdeční v rámci sekundární prevence mezi diabetiky a nemocnými bez diabetu v České republice (studie EUROASPIRE II), Cor Vasa 2004; 46: 55-59.
    5. Danzig V, Šimek S, Šimková R, et al. Ischemická choroba srdeční u diabetiků. 1. vyd. Praha, Maxdorf 2006: 283 s.
    6. Dokainish H, Pillai M, Murphy SA. TACTICS-TIMI-18 Investigators. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy, J Am Coll Cardiol 2005; 45: 19-24. Go to original source... Go to PubMed...
    7. Fox CS, Sullivan L, D'Agostino RB, Wilson PWF. The Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality: The Framingham Heart Study, Diabetes Care 2004; 27: 704-708. Go to original source... Go to PubMed...
    8. Gilbert J, Raboud J, Zinkán B. Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting, Diabetes Care 2004; 27: 990-994. Go to original source... Go to PubMed...
    9. Hammoud T, et al. Léčba koronární nemoci: možnosti u pacientů s diabetes mellitus, JACC-CZ, české vydání. 2001; 1: 31-41.
    10. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial, Lancet 2002; 360: 7-22. Go to original source... Go to PubMed...
    11. Huizar JF, Gonzalez LA, Alderman J, et al. Sulfonylureas attenuate electrocardiographic ST-segment elevation during an acute myocardial infarction in diabetics, J Am Coll Cardiol 2003; 42: 1017-1021. Go to original source... Go to PubMed...
    12. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after succesful implantation of drugeluting stents, JAMA 2005; 293: 2154-2156. Go to original source... Go to PubMed...
    13. Kannel WB, et al. Diabetes and cardiovascular disease: the Framingham study, JAMA 1979; 241: 2035-2038. Go to original source... Go to PubMed...
    14. Keech A, Simek RJ, Barter P, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial, Lancet 2005; 366: 1849-1961. Go to original source... Go to PubMed...
    15. Kvan E, Reikvam A, INPHARM Study Investigators: Thrombolytic treatment in diabetic patients with acute myocardial infarction: lower rates of use than in nondiabetic patients are explained by differences in presenting ECGs, Heart 2004; 90: 1346-1347. Go to original source... Go to PubMed...
    16. Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström A. For the DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity, Eur Heart J 2005; 26: 650-661. Go to original source... Go to PubMed...
    17. Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long term prognosis in patients with unstable angina and nonQwave myocardial infarction: results of the OASIS Registry, Circulation 2000; 102: 1014-1019. Go to original source... Go to PubMed...
    18. McGarry JD. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes, Diabetes 2002; 51: 7-18. Go to original source... Go to PubMed...
    19. Mistrík J. Farmakologická léčba infarktu myokardu u pacientů s diabetes mellitus, Kardiofórum 2004; 2: 27-30.
    20. Norhammar A, Malmberg K, Diderholm E, Lagerqvist B, Lindahl B, Ryden L, Wallentin L. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization, J Am Coll Cardiol 2004; 43: 585-591. Go to original source... Go to PubMed...
    21. Otsuka Y, Myazaki S, Okumura H, et al. Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty, Eur Heart J 2000; 21: 1790-1796. Go to original source... Go to PubMed...
    22. Ralph D´Agostino. CVD risk factors predict diabetes, Diabetes Care 2004; 27: 2234-2240. Go to original source... Go to PubMed...
    23. Rybka J. Diabetes mellitus a kardiovaskulární onemocnění - klinická výzva současnosti, Kardiofórum 2004; 2: 5-10.
    24. Rybka J. Úvodem - znovu zpět k prevenci, Kardiofórum 2004; 2: 4.
    25. Rydén L, Standl E, Bartnik M, Van den Berghe G, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary, EHJ 2007; 28: 88-136. Go to original source...
    26. Steven P, et al. Optimazing the diabetic formulary: betone aspirin and insulin, J Am Coll Cardiol 2002; 40: 652-661. Go to original source... Go to PubMed...
    27. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction, N Engl J Med 2002; 346: 957-966. Go to original source... Go to PubMed...
    28. Šimon J, et al. Epidemiologie a prevence ischemické choroby srdeční. 1. vyd. Praha, Grada Publishing 2001; 264 s.
    29. Špinar J, Vítovec J, et al. Ischemická choroba srdeční. 1. vyd. Praha, Grada Publishing 2003; 364 s.
    30. Topol EJ, Yadav JS, Recognition of the importance of embolization in atherosclerotic vascular disease, Circulation 2000; 101: 570-580. Go to original source... Go to PubMed...
    31. Tschöpe D, Bode CH. Impaired glucose tolerance - a new risk factor? Eur Heart J 2004; 25: 1969. Go to original source... Go to PubMed...
    32. Vybrané ukazatele ze zdravotnické statistiky v SR a ČR 1994-2004. ÚZIS ČR Praha 2006: 140 s. www.uzis.cz.
    33. Zbinden R, Zbinden S, Billinger M, Windecker S, Meier B, Seiler C, Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy, Heart 2005; 91: 1289-1293. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.